Skip to search formSkip to main contentSkip to account menu

BAL5788

Known as: RO 65-5788, BAL 5788, JNJ30982081 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
ABSTRACT Introduction: With resistance of S. aureus, the most prevalent identified pathogen in skin and soft tissue infections… 
2008
2008
ABSTRACT Multidrug-resistant strains of Staphylococcus aureus continue to increase in frequency worldwide, both in hospitals and… 
Review
2006
Review
2006
  • Drugs in R&D
  • 2006
  • Corpus ID: 27518250
Ceftobiprole medocaril [BAL 5788, RO 65-5788, JNJ 30982081] is a prodrug in phase III clinical development with Basilea… 
Highly Cited
2005
Highly Cited
2005
ABSTRACT Ceftobiprole (formerly BAL9141), the active component of the prodrug BAL5788 (ceftobiprole medocaril), is a novel… 
Highly Cited
2004
Highly Cited
2004
ABSTRACT BAL5788 is the water-soluble prodrug of BAL9141, a novel broad-spectrum cephalosporin with potent bactericidal… 
Highly Cited
2004
Highly Cited
2004
ABSTRACT BAL5788 is a water-soluble prodrug of BAL9141, a new broad-spectrum cephalosporin with high levels of in vitro activity… 
Review
2004
Review
2004
  • M. Page
  • Expert opinion on investigational drugs
  • 2004
  • Corpus ID: 7031945
Bacterial resistance to established classes of antibiotics in clinical use is continuing to increase, making the need for new… 
Highly Cited
2004
Highly Cited
2004
ABSTRACT BAL9141, a new antimicrobial agent belonging to the class of parenteral pyrrolidinone-3-ylidenemethyl cephalosporins, is… 
Highly Cited
2002
Highly Cited
2002
ABSTRACT The therapeutic efficacy of BAL9141 (formerly Ro 63-9141), a novel cephalosporin with broad in vitro activity that also…